Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
This bill amends Title 5, United States Code, to add “fertility treatment benefits” as a covered category under the Federal Employees Health Benefits (FEHB) program. It defines covered services broadly — including egg/sperm/embryo preservation, artificial insemination, assisted reproductive technology (like IVF), embryo genetic testing, fertility medications, gamete donation, and other related services as determined by OPM and HHS.
Cost impact: liberals see manageable costs; conservatives fear premium/taxpayer increases.
Targeted benefit expansion for federal employees with administrative framing may attract bipartisan support, but cost concerns and moral objections could produce opposition.
This bill amends Title 5, United States Code, to add “fertility treatment benefits” as a covered category under the Federal Employees Health Benefits (FEHB) program.
It defines covered services broadly — including egg/sperm/embryo preservation, artificial insemination, assisted reproductive technology (like IVF), embryo genetic testing, fertility medications, gamete donation, and other related services as determined by OPM and HHS.
The new coverage requirement would take effect one year after enactment.
Narrow federal benefit expansion improves chances, but cost implications and reproductive/ethical controversies create moderate barriers.
How solid the drafting looks.
Cost impact: liberals see manageable costs; conservatives fear premium/taxpayer increases.
These are examples from the analysis, not a ranked list of the most-affected groups.
Cost impact: liberals see manageable costs; conservatives fear premium/taxpayer increases.
Overall strongly supportive; views the bill as expanding reproductive and family-building access for federal employees, including LGBTQ+ people and cancer survivors.
Sees the broad definitions as remedying inequities in employer coverage and modernizing FEHB benefits.
Generally supportive but cautious; favors expanding coverage for clear medical need while wanting fiscal and implementation clarity.
Would seek measures limiting unforeseen premium spikes or undefined open-ended obligations.
Likely opposed or skeptical; views the bill as expanding federal benefits scope and raising costs.
Has ethical concerns about embryo genetic testing, gamete donation, and potential mandates that conflict with providers' or plan sponsors' beliefs.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow federal benefit expansion improves chances, but cost implications and reproductive/ethical controversies create moderate barriers.
The bill has not accumulated any surfaced votes yet.
Cost impact: liberals see manageable costs; conservatives fear premium/taxpayer increases.
Narrow federal benefit expansion improves chances, but cost implications and reproductive/ethical controversies create moderate barriers.
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Family Building FEHB Fairness Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.